Latham & Watkins represented Tyra Biosciences in the offering while Sidley advised the underwriters.Tyra Biosciences, Inc. has announced the pricing of its upsized initial public offering of 10,800,000…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
